OpenLegislation

Commission Decision of 28 September 2007 concerning a financial contribution from the Community towards a survey on the prevalence of Salmonella spp. in herds of breeding pigs to be carried out in the Member States (notified under document number C(2007) 4434) (2007/636/EC) (repealed)

EU Decision 2007/636 · Adopted 28 September 2007 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Commission Decision

of 28 September 2007

concerning a financial contribution from the Community towards a survey on the prevalence of Salmonella spp. in herds of breeding pigs to be carried out in the Member States

(notified under document number C(2007) 4434)

(2007/636/EC) (repealed)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

Textual amendments

F1

Repealed by 2008/55/EC: Commission Decision of 20 December 2007 concerning a financial contribution from the Community towards a survey on the prevalence of Salmonella spp. and Methicillin-resistant Staphylococcus aureus in herds of breeding pigs to be carried out in the Member States (notified under document number C(2007) 6579).

Contents

  1. 1Subject matter and scope Repealed
  2. 2Definition Repealed
  3. 3Scope of the survey Repealed
  4. 4Performance of sampling and analyses Repealed
  5. 5Conditions for granting a Community financial contribution Repealed
  6. 6Maximum amounts to be reimbursed Repealed
  7. 7Collection of data, assessment and reporting Repealed
  8. 8Conversion rate for expenditure Repealed
  9. 9Application Repealed
  10. 10Addressees Repealed
  11. Signature
  12. Annex I: Technical specifications referred to in Articles 3(1), 4 and 5(2)(b) Repealed
  13. 1OVERVIEW OF THE SURVEY Repealed
  14. SAMPLING FRAME Repealed
  15. 2.1The delineation of the population Repealed
  16. 2.2The sample and the sampling strategy Repealed
  17. 2.2.1First stage: selection of holdings Repealed
  18. 2.2.2Second stage: sampling on the holding Repealed
  19. The sample size calculation Repealed
  20. 2.3.1Primary sample size (first-stage sample size) Repealed
  21. 2.3.2Secondary sample size (second-stage sample size) Repealed
  22. SAMPLE COLLECTION IN THE HERDS Repealed
  23. 3.1Type and detail of the routine sample Repealed
  24. 3.2Additional sampling for the within-holding prevalence study Repealed
  25. 3.3Sample information Repealed
  26. 3.4Transport of samples Repealed
  27. LABORATORY ANALYTICAL METHODS Repealed
  28. 4.1Laboratories Repealed
  29. 4.2Receipt of samples Repealed
  30. 4.3Sample analysis Repealed
  31. 4.3.1Preparation Repealed
  32. Detection and identification methods Repealed
  33. 4.3.2.1Detection of Salmonella Repealed
  34. 4.3.2.2Serotyping of Salmonella Repealed
  35. 4.3.2.3Phage typing of Salmonella Repealed
  36. REPORTING FROM THE MEMBER STATES Repealed
  37. 5.1Overall description on the implementation of the survey Repealed
  38. 5.2Complete data on each holding sampled and corresponding tests results Repealed
  39. 5.2.1The following information shall be collected in Member States for each holding selected for sampling: Repealed
  40. 5.2.2The following information shall be collected in Member States for each sample sent to the laboratory: Repealed
  41. 5.2.3The following additional information shall be collected in Member States for each individual sample sent to the laboratory within the frame of the sampling for the within-holding prevalence: Repealed
  42. Annex IIAnnex II Repealed
  43. Annex IIIAnnex III Repealed

1Subject matter and scopeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2DefinitionF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Scope of the surveyF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4Performance of sampling and analysesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5Conditions for granting a Community financial contributionF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6Maximum amounts to be reimbursedF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7Collection of data, assessment and reportingF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8Conversion rate for expenditureF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9ApplicationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10AddresseesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1OVERVIEW OF THE SURVEYF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.1The delineation of the populationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.2The sample and the sampling strategyF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.2.1First stage: selection of holdingsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.2.2Second stage: sampling on the holdingF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.3.1Primary sample size (first-stage sample size)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2.3.2Secondary sample size (second-stage sample size)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3.1Type and detail of the routine sampleF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3.2Additional sampling for the within-holding prevalence studyF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3.3Sample informationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3.4Transport of samplesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.1LaboratoriesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.2Receipt of samplesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.3Sample analysisF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.3.1PreparationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.3.2.1Detection of SalmonellaF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.3.2.2Serotyping of SalmonellaF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.3.2.3Phage typing of SalmonellaF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5.1Overall description on the implementation of the surveyF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5.2Complete data on each holding sampled and corresponding tests resultsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5.2.1The following information shall be collected in Member States for each holding selected for sampling:F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5.2.2The following information shall be collected in Member States for each sample sent to the laboratory:F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5.2.3The following additional information shall be collected in Member States for each individual sample sent to the laboratory within the frame of the sampling for the within-holding prevalence:F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex IIF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex IIIF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .